Literature DB >> 23427882

Dengue vaccine efficacy trial: does interference cause failure?

Sathyamangalam Swaminathan1, Navin Khanna, Belinda Herring, Suresh Mahalingam.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23427882     DOI： 10.1016/S1473-3099(13)70028-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN： 1473-3099            Impact factor:   25.071


× No keyword cloud information.
  13 in total

1.  Potent Plasmablast-Derived Antibodies Elicited by the National Institutes of Health Dengue Vaccine.

Authors:  Diogo M Magnani; Cassia G T Silveira; Michael J Ricciardi; Lucas Gonzalez-Nieto; Núria Pedreño-Lopez; Varian K Bailey; Martin J Gutman; Helen S Maxwell; Aline Domingues; Priscilla R Costa; Lilian Ferrari; Raphaella Goulart; Mauricio A Martins; José M Martinez-Navio; Sebastian P Fuchs; Jorge Kalil; Maria do Carmo Timenetsky; Jens Wrammert; Stephen S Whitehead; Dennis R Burton; Ronald C Desrosiers; Esper G Kallas; David I Watkins
Journal:  J Virol       Date:  2017-10-27       Impact factor: 5.103

2.  Interference Between Respiratory Syncytial Virus and Human Rhinovirus Infection in Infancy.

Authors:  Niek B Achten; Pingsheng Wu; Louis Bont; Maarten O Blanken; Tebeb Gebretsadik; James D Chappell; Li Wang; Chang Yu; Emma K Larkin; Kecia N Carroll; Larry J Anderson; Martin L Moore; Chantel D Sloan; Tina V Hartert
Journal:  J Infect Dis       Date:  2017-04-01       Impact factor: 5.226

3.  Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.

Authors:  Niyati Khetarpal; Rahul Shukla; Ravi Kant Rajpoot; Ankur Poddar; Meena Pal; Sathyamangalam Swaminathan; Upasana Arora; Navin Khanna
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

4.  A small molecule inhibitor of dengue virus type 2 protease inhibits the replication of all four dengue virus serotypes in cell culture.

Authors:  Rajendra Raut; Hemalatha Beesetti; Poornima Tyagi; Ira Khanna; Swatantra K Jain; Variam U Jeankumar; Perumal Yogeeswari; Dharmarajan Sriram; Sathyamangalam Swaminathan
Journal:  Virol J       Date:  2015-02-08       Impact factor: 4.099

Review 5.  Understanding the dengue viruses and progress towards their control.

Authors:  Rosmari Rodriguez-Roche; Ernest A Gould
Journal:  Biomed Res Int       Date:  2013-07-09       Impact factor: 3.411

6.  Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.

Authors:  Lav Tripathi; Shailendra Mani; Rajendra Raut; Ankur Poddar; Poornima Tyagi; Upasana Arora; Aravinda de Silva; Sathyamangalam Swaminathan; Navin Khanna
Journal:  Front Microbiol       Date:  2015-09-23       Impact factor: 5.640

7.  Induction of neutralizing antibodies against four serotypes of dengue viruses by MixBiEDIII, a tetravalent dengue vaccine.

Authors:  Hui Zhao; Tao Jiang; Xi-Zhen Zhou; Yong-Qiang Deng; Xiao-Feng Li; Shui-Ping Chen; Shun-Ya Zhu; Xi Zhou; E-De Qin; Cheng-Feng Qin
Journal:  PLoS One       Date:  2014-01-21       Impact factor: 3.240

8.  Induction of neutralizing antibody response against four dengue viruses in mice by intramuscular electroporation of tetravalent DNA vaccines.

Authors:  Eakachai Prompetchara; Chutitorn Ketloy; Poonsook Keelapang; Nopporn Sittisombut; Kiat Ruxrungtham
Journal:  PLoS One       Date:  2014-06-02       Impact factor: 3.240

Review 9.  Vaccines for the 21st century.

Authors:  Isabel Delany; Rino Rappuoli; Ennio De Gregorio
Journal:  EMBO Mol Med       Date:  2014-04-06       Impact factor: 12.137

10.  Cissampelos pareira Linn: Natural Source of Potent Antiviral Activity against All Four Dengue Virus Serotypes.

Authors:  Ruchi Sood; Rajendra Raut; Poornima Tyagi; Pawan Kumar Pareek; Tarani Kanta Barman; Smita Singhal; Raj Kumar Shirumalla; Vijay Kanoje; Ramesh Subbarayan; Ravisankar Rajerethinam; Navin Sharma; Anil Kanaujia; Gyanesh Shukla; Y K Gupta; Chandra K Katiyar; Pradip K Bhatnagar; Dilip J Upadhyay; Sathyamangalam Swaminathan; Navin Khanna
Journal:  PLoS Negl Trop Dis       Date:  2015-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.